BACK
Series
CEO on the Spot
The Big Debate
The State of Decision-Making
Three-minute explainers
The CEO Index
The Data Leaders 25
Sponsored by Salesforce
This could’ve been an email
Sponsored by mailchimp
Growth Experience
Sponsored by HSBC UK
Topics
HR
Talent & Culture
Future of Work
Diversity & Inclusion
Employee Engagement
The Modern Workforce
All HR
Technology
Mastering AI
Cloud
Cybersecurity
Data Analytics
Digital Transformation
All Technology
Finance
Economy
Growth Strategies
Financial Services
Fintech
Risk
All Finance
Marketing
Advertising
B2B
B2C
CX
Design & Innovation
Effectiveness
All Marketing
Leadership
CEO on the spot
Green Insights
Legal
Responsible Business
All Leadership
Newsletters
Opinion
Reports
Special Reports
Insight Reports
Infographics
Roundtables
Roundtables
Register your interest
Strategic Guides
Unlocking resources with AI
Raconteur 50
Services
Advertising
Careers
Contact
Twitter
Linkedin
Instagram
Facebook
Raconteur
NEWSLETTER
My account
Sign In
HR
Technology
Finance
Marketing
Leadership
Pharmaceuticals
Healthcare
Does big pharma’s R&D justify high drug prices?
Global Business
What we can learn from the Covid vaccine success
Healthcare
Have Covid-19 vaccines changed intellectual property for good?
Global Business
China vs. India: the fight for pharma supremacy
Latest articles
Healthcare
How Covid is building trust in Big Pharma
Global Business
Is it time to rehabilitate psychedelics?
Global Business
The real dangers of vaccine hesitancy
Healthcare
Can weight-loss drugs tackle the obesity crisis?
Healthcare
How COVID-19 is evolving the R&D landscape
Healthcare
Medical cannabis and the ongoing fight for access
Healthcare
What are new antibiotics really worth?
Global Business
India: a global pharma powerhouse
More Articles
